Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Esophageal Squamous Cell Carcinoma × Vorinostat × 30 days × Clear all

Sponsor

Conditions

Myelodysplastic Syndromes 2 Leukemia, Myelomonocytic, Chronic 2 Anemia, Refractory, with Excess of Blasts 2 Uveal Melanoma 1 Recurrence 1 Oligodendroglioma 1 Neuroblastoma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Extranodal NK-T-Cell 1 Leukemia, Myeloid, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Gliosarcoma 1 Glioma 1 Glioblastoma 1 GATA2 Deficiency 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1 Anemia, Refractory 1

Interventions

pembrolizumab 7 Cisplatin 6 Paclitaxel 5 Drug Therapy 3 toripalimab 2 Radiotherapy 2 Irinotecan 2 Fluorouracil 2 Carboplatin 2 tislelizumab 1 regorafenib 1 osimertinib 1 nimotuzumab 1 lenvatinib 1 aflibercept 1 Oxaliplatin 1 Nivolumab 1 NEO212 1 Levoleucovorin 1 Leucovorin 1 Ipilimumab 1 IFL protocol 1 Histamine H2 Antagonists 1 Histamine Antagonists 1 Fulvestrant 1 Docetaxel 1 Dexamethasone 1 Chemoradiotherapy 1 Bevacizumab 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡